Artificial Neural Networks as a Way to Predict Future Kidney Cancer Incidence in the United States-Reference-Cited by-同舟云学术

Artificial Neural Networks as a Way to Predict Future Kidney Cancer Incidence in the United States

Published:2021-04 Issue:2 Volume:19 Page:e84-e91
ISSN:1558-7673
Container-title:Clinical Genitourinary Cancer
language:en
Short-container-title:Clinical Genitourinary Cancer

Author:

Santoni Matteo,Piva Francesco,Porta Camillo,Bracarda Sergio,Heng Daniel Y.,Matrana Marc R.,Grande Enrique^ORCID,Mollica Veronica,Aurilio Gaetano,Rizzo Mimma^ORCID,Giulietti Matteo,Montironi Rodolfo,Massari Francesco^ORCID

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference27 articles.

1. Epidemiology and risk factors for kidney cancer;Chow;Nat Rev Urol,2010

2. Advances in the diagnosis of hereditary kidney cancer: initial results of a multigene panel test;Nguyen;Cancer,2017

3. Renal cell tumors: understanding their molecular pathological epidemiology and the 2016 WHO classification;Inamura;Int J Mol Sci,2017

4. The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs—Part B: Prostate and Bladder Tumours;Humphrey;Eur Urol,2016

5. Renal cell carcinoma;Cairns;Cancer Biomark,2010

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical outcome predictors for metastatic renal cell carcinoma: a retrospective multicenter real-life case series;BMC Cancer;2024-07-05

2. Numerical paradigm to explore the chemically reacting Williamson nanofluid flow with the influence of bioconvection effects using neural networks;Numerical Heat Transfer, Part A: Applications;2024-04-17

3. Evaluation of Applied Artificial Neuronal Networks with a Timely Cervical Cancer Diagnosis in an Emerging Economy;Management and Industrial Engineering;2024

4. Genomic Profiling and Molecular Characterization of Clear Cell Renal Cell Carcinoma;Current Oncology;2023-10-20

5. Clinico-Pathological Features Influencing the Prognostic Role of Body Mass Index in Patients With Advanced Renal Cell Carcinoma Treated by Immuno-Oncology Combinations (ARON-1);Clinical Genitourinary Cancer;2023-10